Clinical Trial

Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects

Name: Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects — clinical trial record (NCT07345442)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

PA9159 is a highly potent novel corticosteroid. The purpose of this study is to exam the safety, tolerability, and pharmacokinetics of single and repeat dosing of intranasal PA9159, to establish maximum tolerated dose in healthy chinese adult

Trial Details

NCT Number	NCT07345442
Lead Sponsor	Anhui Palo Alto Pharmaceuticals, Inc.
Conditions	Allergic Rhinitis
Enrollment	36 participants
Start Date	2025-03-14
Primary Completion	2025-06-09 (estimated)
Study Completion	2025-06-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-15